Supplementary Data — Xiannuoxin for COVID-19: real-time meta analysis of 2 studies

@CovidAnalysis, November 2025, Version 1V1
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Cao (DB RCT) 17% 0.83 [0.74-0.94] recov. time 504 (n) 503 (n) Improvement, RR [CI] Treatment Control Wang (DB RCT) 68% 0.32 [0.10-1.03] recovery 12 (n) 8 (n) Wang (DB RCT) 48% 0.52 [0.18-1.52] recovery 10 (n) 8 (n) Wang (DB RCT) 38% 0.62 [0.34-1.12] viral load 12 (n) 8 (n) Wang (DB RCT) 14% 0.86 [0.47-1.57] viral load 12 (n) 8 (n) Xiannuoxin COVID-19 outcomes c19early.org November 2025 Favors xiannuoxin Favors control
Fig. S1. All outcomes.